The 2012 issue of Bioscience Colorado highlights centers of excellence within the state, including Cancer, Infectious Disease, Respiratory, Cardiac and Biofuels. The research the writers and experts have compiled for this issue illustrates that there are several components—infrastructure, expertise, industry connections, and patient outcomes. Each article focuses on a center and examines the elements that make it truly excellent.
The new issue also includes:
* Complete listing of every bioscience company in the state
* Annual industry financing and investment overview
* Bioscience Discovery Evaluation Grant Program (BDEGP) update
This publication is an integral part of the Association’s mission to support the Colorado bioscience community through advocacy, resources and advancement of opportunities for collaboration. It reaches thousands of bioscience, economic development, legislative, university and industry leaders.
The new magazine rolls out the industry’s new branding campaign for Bioscience in Colorado: Elevated Thinking. We have some of the top research institutions in the country and over 600 bioscience companies led by the best in the industry—creating the vision and drive to succeed. That’s why so many great ideas that impact the globe start and grow here in Colorado.
Link to the magazine pdf
Link to the Business Wire release
Link to the PitchEngine Social Media newswire
Friday, June 15, 2012
Sunday, June 3, 2012
2012 Class of 'Boettcher Investigators' Announced
The Boettcher Foundation Board of Trustees has released the names of the three early-career scientists selected for the third class of Boettcher Investigators in the Webb-Waring Biomedical Research Program.
Timothy W. Schultz, President and Executive Director of the Boettcher Foundation, said "Through this program, the Boettcher Foundation has been able to bring resources to an area where funds are currently lacking and where federal and private research programs provide limited support. Early-career investigators quite frequently have a difficult time securing a first opportunity at an independent research effort that will move them out of the laboratory of their mentors and onto their own new and exciting areas of discovery."
The 2012 (third) Class of Boettcher Investigators in the Webb-Waring Biomedical Research Program includes:
* Harald Junge, Ph.D. , University of Colorado at Boulder, Retinal Vascular Development and Disease
* Matthew Kennedy, Ph.D., University of Colorado – Anschutz Medical Campus, Molecular Mechanisms of Alzheimer's Pathology
* Chad G. Pearson, Ph.D., University of Colorado – Anschutz Medical Campus, Organization of the Microtubule Cytoskeleton for Cell Division and Signaling
With the addition of the 2012 Class, there are now fourteen Boettcher Investigators conducting research in the following Colorado institutions: University of Colorado Anschutz Medical Campus, University of Colorado Boulder, Colorado State University, National Jewish Health and Colorado School of Mines.
Link to the Business Wire release
Link to the PitchEngine Social Media Release
Timothy W. Schultz, President and Executive Director of the Boettcher Foundation, said "Through this program, the Boettcher Foundation has been able to bring resources to an area where funds are currently lacking and where federal and private research programs provide limited support. Early-career investigators quite frequently have a difficult time securing a first opportunity at an independent research effort that will move them out of the laboratory of their mentors and onto their own new and exciting areas of discovery."
The 2012 (third) Class of Boettcher Investigators in the Webb-Waring Biomedical Research Program includes:
* Harald Junge, Ph.D. , University of Colorado at Boulder, Retinal Vascular Development and Disease
* Matthew Kennedy, Ph.D., University of Colorado – Anschutz Medical Campus, Molecular Mechanisms of Alzheimer's Pathology
* Chad G. Pearson, Ph.D., University of Colorado – Anschutz Medical Campus, Organization of the Microtubule Cytoskeleton for Cell Division and Signaling
With the addition of the 2012 Class, there are now fourteen Boettcher Investigators conducting research in the following Colorado institutions: University of Colorado Anschutz Medical Campus, University of Colorado Boulder, Colorado State University, National Jewish Health and Colorado School of Mines.
Link to the Business Wire release
Link to the PitchEngine Social Media Release
Subscribe to:
Posts (Atom)